• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

    3.955 +0.085 (+2.20%)
    Streaming Delayed Price Updated: 12:11 PM EDT, Aug 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Bicycle Therapeutics plc - American Depositary Shares

    < Previous 1 2 3 4 5 Next >
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Strengthens Board of Directors with New Appointments
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
    From Bicycle Therapeutics
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.